PTPA and neurodegenerative disease: PP2A was reported to participate in various neurodegenerative diseases, and, in particular, inhibition of PP2A activity was found in sporadic Alzheimer's disease (AD), focal cerebral ischemia and traumatic brain injury (Koh, 2011; Sontag and Sontag, 2014; Shultz et al., 2015).